Article Versions Notes

Eibenschutz L, Caputo S, Camera E, Carbone A, Silipo V, Migliano E, Aurizi C, Cota C, Frascione P, Bellei B. Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts? Cancers. 2021; 13(22):5858. https://doi.org/10.3390/cancers13225858

Eibenschutz, Laura, Silvia Caputo, Emanuela Camera, Anna Carbone, Vitaliano Silipo, Emilia Migliano, Caterina Aurizi, Carlo Cota, Pasquale Frascione, and Barbara Bellei. 2021. "Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?" Cancers 13, no. 22: 5858. https://doi.org/10.3390/cancers13225858

Eibenschutz, L., Caputo, S., Camera, E., Carbone, A., Silipo, V., Migliano, E., Aurizi, C., Cota, C., Frascione, P., & Bellei, B. (2021). Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts? Cancers, 13(22), 5858. https://doi.org/10.3390/cancers13225858